Versigent Forecast, price target & analysts
Versigent Target price 2026 - Analyst rating & recommendation
Versigent Classifications & Recommendation
Versigent Price Target
| Target Price | $56.61 |
| Price | $46.43 |
| Potential |
21.93%
register free of charge
|
| Number of Estimates | 12 |
|
12 Analysts have issued a price target Versigent 2027 .
The average Versigent target price is $56.61.
This is
21.93%
register free of charge
$63.00
35.69%
register free of charge
$52.52
13.12%
register free of charge
|
|
| A rating was issued by 18 analysts: 16 Analysts recommend Versigent to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Versigent stock has an average upside potential 2027 of
21.93%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 8.82 | 9.70 |
| 6.13% | 9.98% | |
| EBITDA Margin | 7.55% | 10.47% |
| 11.47% | 38.63% | |
| Net Margin | 5.99% | 5.42% |
| 21.94% | 9.48% |
13 Analysts have issued a sales forecast Versigent 2026 . The average Versigent sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Versigent EBITDA forecast 2026. The average Versigent EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Versigent Analysts have issued a net profit forecast 2026. The average Versigent net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 7.43 | 7.43 |
| 29.44% | 0.00% | |
| P/E | 6.25 | |
| EV/Sales | 0.51 |
13 Analysts have issued a Versigent forecast for earnings per share. The average Versigent EPS is
This results in the following potential growth metrics and future valuations:
Current Versigent Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Argus Research |
Locked
➜
Locked
|
Locked | Aug 13 2026 |
| Evercore ISI Group |
Locked
➜
Locked
|
Locked | Aug 10 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Jul 20 2026 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Argus Research:
Locked
➜
Locked
|
Aug 13 2026 |
|
Locked
Evercore ISI Group:
Locked
➜
Locked
|
Aug 10 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Jul 20 2026 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Jul 13 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
